Market Insights programs form an integral component of AMCP's efforts to identify deeper insights to guide coverage, access, and clinical management decisions. This non-promotional, sponsored webinar will review health plan best practice recommendations for Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC) with an expert panel of oncology and managed care experts.
Given the central role of managed care and payer professionals in enhancing the value and accessibility of cancer care, comprehending the best practices for biomarker testing in NSCLC is paramount. These best practices have been developed through expert interviews, a nationwide survey, and multistakeholder workshop, and are founded on the discoveries from the Market Insights program focused on Bridging the Gaps in Precision Oncology: Opportunities in NSCLC.
During this webinar, our panel of experts will delve into health plan best practices concerning biomarker testing in NSCLC, present the results of a national survey among managed care oncology professionals, and explore the elements of high-quality care that can advance health equity and address unmet needs in NSCLC. Following the presentation, there will be an opportunity to engage with the panelists during a live Q&A session.